Real-Time In Vivo Characterization of Primary Liver Tumors With Diffuse Optical Spectroscopy During Percutaneous Needle Interventions: Feasibility Study in Woodchucks by Nachabé, Rami et al.
ORIGINAL ARTICLE
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
75
56
3 
| 
do
wn
lo
ad
ed
: 
13
.3
.2
01
7Real-Time In Vivo Characterization of Primary Liver Tumors
With Diffuse Optical Spectroscopy During Percutaneous
Needle Interventions
Feasibility Study in WoodchucksRami Nachabé, PhD, MSc,* Benno H.W. Hendriks, PhD,† Ross Schierling, RT,‡ Jasmine Hales, VT,§
Judy M. Racadio, MD,‡ Sven Rottenberg, DVM,k Theo J.M. Ruers, MD, PhD,¶
Drazenko Babic, MD,* and John M. Racadio, MD‡Objective: This study presents the first in vivo real-time optical tissue charac-
terization during image-guided percutaneous intervention using near-infrared
diffuse optical spectroscopy sensing at the tip of a needle. The goal of this
study was to indicate transition boundaries from healthy tissue to tumors,
namely, hepatic carcinoma, based on the real-time feedback derived from the
optical measurements.
Materials and Methods: Five woodchucks with hepatic carcinoma were used
for this study. Thewoodchucks were imaged with contrast-enhanced cone beam
computed tomography with a flat panel detector C-arm system to visualize the
carcinoma in the liver. In each animal, 3 insertions were performed, starting
from the skin surface toward the hepatic carcinoma under image guidance. In
2 woodchucks, each end point of the insertion was confirmed with pathologic
examination of a biopsy sample. While advancing the needle in the animals un-
der image guidance such as fluoroscopy overlaid with cone beam computed to-
mography slice and ultrasound, optical spectra were acquired at the distal end of
the needles. Optical tissue characterization was determined by translating the
acquired optical spectra into clinical parameters such as blood, water, lipid,
and bile fractions; tissue oxygenation levels; and scattering amplitude related
to tissue density. The Kruskal-Wallis test was used to study the difference in
the derived clinical parameters from the measurements performed within the
healthy tissue and the hepatic carcinoma. Kurtoses were calculated to assess
the dispersion of these parameters within the healthy and carcinoma tissues.
Results: Blood and lipid volume fractions as well as tissue oxygenation and re-
duced scattering amplitude showed to be significantly different between the
healthy part of the liver and the hepatic carcinoma (P < 0.05) being higher in nor-
mal liver tissue. A decrease in blood and lipid volume fractions and tissue oxy-
genation as well as an increase in scattering amplitude were observed when the
tip of the needle crossed the margin from the healthy liver tissue to the carcinoma.
The kurtosis for each derived clinical parameter was high in the hepatic tumor
as compared with that in the healthy liver indicating intracarcinoma variability.
Conclusions: Tissue blood content, oxygenation level, lipid content, and tissue
density all showed significant differences when the needle tip was guided from
the healthy tissue to the carcinoma and can therefore be used to identify tissue
boundaries during percutaneous image-guided interventions.
Key Words: near-infrared spectroscopy, hepatic carcinoma, interventional
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L ast decade, the percentage of image-guided percutaneous biopsieshas continuously increased at the expense of non–imaging-guided
percutaneous approaches, which is likely related to the increasing use
of advanced imaging modalities for biopsy guidance. As a conse-
quence, recent trends indicate that radiologists will be performing an in-
creasing amount of percutaneous needle biopsies. An increase of
roughly 15% of biopsies by percutaneous approach over the last decade
was observed across all anatomical regions.1
Nevertheless, despite the recent advances in imaging modalities
to improve percutaneous needle guidance under imaging, biopsies do
not always yield histological diagnostic samples. Diagnostic yield is de-
pendent on several parameters such as lesion-related factors including
lesion type and size as well as technical factors such as needle gauge,
biopsied specimen size, amount of biopsied specimens within a lesion,
and type of imaging modality for guidance. Most commonly used mo-
dalities are fluoroscopy, ultrasound (US), computed tomography (CT),
CT fluoroscopy, magnetic resonance (MR) imaging, and, more recently,
multimodality such as 3-dimensional (3D) fluoroscopy consisting of
combining cone beam CT (CBCT) with live fluoroscopy from a C-arm
system2 or even either positron emission tomography, CT, or MR
overlaid with 3D fluoroscopy.3–6
Diffuse optical spectroscopy (DOS) is an emerging technique
for optical tissue characterization. This technique consists of studying
the spectral light response after illuminating tissue with a light source.
The collected optical spectra are translated into clinically relevant pa-
rameters such as blood, water, lipid, and bile fractions; tissue oxygen-
ation levels; and tissue density related to the scattering of light.7 In
recent research, several advances have been made in integrating opti-
cal fibers into needlelike probes for DOS measurements at the distal
end of the devices.8–10 Most of the DOS clinical studies have ad-
dressed the diagnostic performance in discriminating tumors from
the normal tissue. These clinical experiments consisted of performing
several point measurements at different locations in tumors and
healthy tissue. The diagnostic performance of DOS has generally been
evaluated by comparing the tissue classification from themeasurements
with the actual tissue type as identified with pathologic examination8,9
or diagnostic medical imaging.8,10 A few in vivo studies have been con-
ducted to demonstrate that DOS enables tissue discrimination, namely,
discrimination of malignant tissue from healthy tissue.8–10 In most of
these cases, image guidance was used to confirm the location of the
tip of the probe.8,10 All of the studies investigated the diagnosis perfor-
mance of DOS but not its ability to provide the physician with real-time
feedback on the guidance of the needle from normal to tumor tissue
based on DOS. We hypothesize that continuous measurements would
be of great relevance during percutaneous procedures because they
enable detection of the transition from healthy tissue to tumor based
on the clinical parameters derived from optical spectroscopy. Inwww.investigativeradiology.com 443
ealth, Inc. All rights reserved.
FIGURE 1. Schematic drawing of the optical setup (A) and the design of the optical needle tip (B).
Nachabé et al Investigative Radiology • Volume 50, Number 7, July 2015addition, it would provide a profile of the tissue along the needle path
yielding data on intrasubject heterogeneity.
To this aim, we applied continuous DOS measurements under
3D fluoroscopy and US guidance in woodchucks with hepatocellular
carcinoma (HCC) tumor to evaluate the added value of continuous mea-
surements during percutaneous insertions.FIGURE 2. A, Cone beam CT slice depicts a virtual needle path (green
line) with the entry point (magenta marker) defined at the skin surface
and the end target in the middle of the round tumor. The small and
large dash markers along the virtual line correspond to millimeter and
centimeter spacing, respectively. The white arrows indicate the
boundaries of the tumor along the virtual line (B). Cone beam CT
overlayed with live fluoroscopy (ie, 3D fluoroscopy) demonstrates the
tumor in the liver (boundaries indicated by white arrows). The green
line corresponds to the virtual needle trajectory. The needle has been
advanced along the virtual needle path, and the tip is now in the
center of the tumor. C, Photograph of the liver with a cut section
through the tumor. The thickness of the tumor is roughly 1 cm as can
also be seen in B and C. Figure 2 can be viewed online in color at
www.investigativeradiology.com.MATERIALS AND METHODS
Animal Model and Measurement Protocol
All procedures in this study followed the guidelines of the Insti-
tutional Animal Care and Use Committee of Cincinnati Children's Hos-
pital Medical Centre and were approved by the ethics committee.
Fivewoodchucks with HCC induced by thewoodchuck hepatitis
virus infection were used; they were ordered from Northeastern Wild-
life Inc and weighed an average of 2.5 kg. The animals were initially se-
dated with an intramuscular injection of 5 mg/kg of xylazine (Fort
Dodge Laboratories, Kansas City, MO) and 50 mg/kg of ketamine (Fort
Dodge Laboratories). All animals were placed under general anesthesia
by using 1% to 5% isoflurane (Halocarbon Products Co, New Jersey,
NY) administered through endotracheal tube. For intravenous contrast
agent administration, a 20-gauge angiocatheter (Cook Medical Inc,
Bloomington, IN) was placed into the femoral vein using direct US
guidance after shaving the skin of the animals and making a small inci-
sion. Each animalwas used for 2 to 4 separate needle insertions with as-
sociated measurements and was then euthanized at the end of the
experimental day with an intravenous injection of 1 mL/5 kg of Fatal-
Plus (Vortech Pharmaceuticals, Dearborn, MI).
Diffuse Optical Spectroscopy
A research prototype setup (Fig. 1A) that allows optical spectros-
copy measurements of tissue via optical fibers integrated in a needle
was used in this study.7 In short, the setup includes a light source and
2 optical spectrometers that enable light detection in the visible and
near-infrared wavelength range. A custom-made needle is connected
to the light source and to both spectrometers via optical fibers. The op-
tical needle is an 18-gauge needle with a 70-degree angled tip (Fig. 1B),
whereas the fiber ends are cut straight. The fiber ends between source
and detector fibers used in this study are 1.84 mm apart. This needle
can perform optical spectroscopy measurements at its tip.
The light emitted at the tip of the needle travels through the tis-
sue before reaching the collecting fiber and is subject to optical absorp-
tion and scattering. The measurement acquisition time per spectrum
is 300 milliseconds. An analytical model was used to derive the va-
rious physiological and morphological properties from each spectrum
using a mathematical model that describes tissue-light interaction.7444 www.investigativeradiology.com © 2015 Wolters Kluwer Health, Inc. All rights reserved.
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Investigative Radiology • Volume 50, Number 7, July 2015 In Vivo Characterization of Primary Liver TumorsThe physiological and morphological properties that were derived from
each spectrum included biological volume fractions (blood, water, lipid,
and bile), oxygenation level of blood, and light scattering due to
tissue density.
Image Guidance
The needle insertions were performed under 3D fluoroscopy
(XperGuide; Philips Healthcare, Best, the Netherlands). Whereas US
is a common imaging technique used for needle guidance, 3D fluoros-
copy is a more recent technique that consists of overlaying live x-ray
fluoroscopy with CBCT.2 A 3D soft tissue CBCT data set was acquired
after injection of a contrast agent (Optiray 350; Covidien, Hazelwood,
MI) for better visualization of the tumor and the surrounding healthy
tissue. From the 3D data set, an optimal CBCT slice with the tumor
clearly visible was selected to define a planned needle path. The needle
planning was interactively performed by drawing a line from the center
of the tumor toward the skin surface (Fig. 2). Live 3D fluoroscopy and
US imaging were acquired simultaneously with DOS acquisition to as-
sure registration of the tissue characterization with the actual location of
the needle tip. A total of 9 insertions were performed in the animals. At
the end of the experiment, the liver was excised for gross tissue investi-
gation. A cut-through was performed along the needle path in the tumor
to observe the tissue structure, and a tissue biopsy at the last position of
the needle was obtained for histological investigation.
Data Collection and Analysis
While the needle was advanced under live 3D fluoroscopy, opti-
cal spectra were acquired every 300 milliseconds and the real-time data
analytical model converted the data into clinical information listed in
the previous section concerning DOS. Once the final target was
reached, a biopsy was taken for further pathologic investigation and cor-
relation with the DOS information.FIGURE 3. A and B, Pictures of an excised liver of one of the woodchucks. Tis
pathology shown in C to F and optical spectra shown in G to J, respectively. G
fitted spectrum, and the green line is the scattering contribution to the spectr
www.investigativeradiology.com.
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Copyright © 2015 Wolters Kluwer HPathologic Analysis
The obtained tissue samples after being fixated in formalin were
paraffin-embedded, cut in approximately 2-μm-thick sections, and
stained with hematoxylin and eosin staining. The slices were histologi-
cally investigated by a veterinary pathologist.
Statistical Analysis
For each of the parameters derived from the spectral measure-
ments, statistical analyses were performed using the nonparametric
Kruskal-Wallis test for differences between normal and tumor for each
insertion with a significance level of 5%. Kurtoses were computed to
assess the dispersion for each parameter derived from measurements
in both types of tissue. All statistical analyses were donewith a data pro-
cessing software (MATLAB; MathWorks, Natick, MA).
RESULTS
In the liver of the woodchucks, typically more than 1 lesion was
present. In Figure 3, an example of excised liver with tumors is shown,
revealing at least 3 different types of lesions. For the locations indi-
cated in Figure 3B, pathology was performed with the images of the
slides shown in Figure 3, C to F, with corresponding measured
optical spectra shown in Figure 3, G to J. The 3 lesions, cut open in
Figure 3B, have a different macroscopic appearance, which is also
reflected in observable differences in the spectra. The histology
images of the different locations show that, in addition to the liver
neoplasia, there is multifocal necrosis with neutrophils and
macrophages as well as fibrosis, which indicates chronic hepatitis and
cirrhosis. The tumors are of the trabecular type and solid type. The
neoplasms lack portal areas but otherwise still resemble the liver
architecture. Nuclear pleomorphism is limited, as well as the mitotic
figure, indicating that these neoplasms are borderline carcinomas.
In the necrotic lesion 4 of Figure 3F, a high amount of fat droplets
is observed. The corresponding optical spectrum (Fig. 3J) reveals asue samples were taken at locations 1 to 4 with corresponding
–J, The blue line is the measured spectrum, the red line is the
um determined by fitting. Figure 3 can be viewed online in color at
www.investigativeradiology.com 445
ealth, Inc. All rights reserved.
TABLE 1. Mean (SD) for Each Derived Parameter and Each Insertion
Normal Tumor
Insertion 1 n = 38 n = 31
Blood volume fraction* 13.2 (4.4) 7.5 (5.6)
Tissue oxygenation* 19 (9) 3.3 (5.8)
Lipid volume fraction* 7 (2) 5 (3)
Scattering amplitude* 11.0 (1.2) 11.6 (1)
Bile volume fraction* 3 (2) 4 (1)
Collagen volume fraction* 2 (1) 9 (2)
Insertion 2 n = 50 n = 15
Blood volume fraction* 19.4 (2.6) 16.1 (0.8)
Tissue oxygenation* 85 (10) 69 (1)
Lipid volume fraction* 25 (9) 9 (2)
Scattering amplitude* 9.3 (0.5) 9 (0.1)
Bile volume fraction 0 (0) 0 (0)
Collagen volume fraction* 8 (7) 21 (3)
Insertion 3 n = 37 n = 120
Blood volume fraction* 9.1 (3.5) 6.3 (2.5)
Tissue oxygenation* 53 (16) 30 (15)
Lipid volume fraction* 6 (8) 11 (7)
Scattering amplitude* 9.4 (1.7) 11.5 (1.3)
Bile volume fraction 8 (2) 7 (1)
Collagen volume fraction* 22 (11) 5 (3)
Insertion 4 n = 10 n = 47
Blood volume fraction* 5.7 (0.6) 0.9 (0.7)
Tissue oxygenation* 55 (2) 22 (8)
Lipid volume fraction* 4 (1) 1 (1)
Scattering amplitude* 8.5 (0.2) 11.3 (1.8)
Bile volume fraction* 4 (1) 1 (1)
Collagen volume fraction* 0 (0) 3 (1)
Insertion 5 n = 44 n = 16
Blood volume fraction* 19.5 (1.9) 2.8 (2.4)
Tissue oxygenation* 65 (3) 35 (20)
Lipid volume fraction* 5 (1) 4 (1)
Scattering amplitude 6.3 (0.6) 7.4 (2.2)
Bile volume fraction* 7 (1) 1 (1)
Collagen volume fraction* 2 (2) 0 (0)
Insertion 6 n = 11 n = 69
Blood volume fraction 15.2 (4.3) 17.9 (4.3)
Tissue oxygenation* 75 (2) 72 (2)
Lipid volume fraction* 4 (1) 2 (1)
Scattering amplitude* 6.4 (0.3) 8.6 (0.8)
Bile volume fraction* 4 (1) 7 (1)
Collagen volume fraction* 0 (0) 0 (0)
Insertion 7 n = 65 n = 55
Blood volume fraction 6.2 (0.3) 6.7 (3.3)
Tissue oxygenation* 46 (5) 15 (11)
Lipid volume fraction* 45 (1) 16 (13)
Scattering amplitude 26 (1) 25 (14)
Bile volume fraction* 1 (1) 5 (3)
Collagen volume fraction 4 (3) 3 (5)
Insertion 8 n = 73 n = 64
Blood volume fraction* 52.7 (6.3) 12.6 (9.4)
Tissue oxygenation* 38 (18) 10 (11)
Lipid volume fraction* 15 (6) 25 (6)
Continued next page
TABLE 1. (Continued)
Normal Tumor
Scattering amplitude* 12.7 (0.9) 19.7 (8.3)
Bile volume fraction 2 (2) 1 (2)
Collagen volume fraction* 1 (3) 7 (11)
Insertion 9 n = 231 n = 50
Blood volume fraction* 8.7 (4.1) 2.8 (3.1)
Tissue oxygenation* 72 (15) 32 (15)
Lipid volume fraction* 20 (25) 70 (28)
Scattering amplitude 13.7 (9.9) 14.1 (21.5)
Bile volume fraction 1 (1) 0 (0)
Collagen volume fraction* 4 (4) 1 (2)
Mean (SD) of the estimated blood volume fraction, blood oxygenation, lipid
volume fraction, scattering amplitude, bile volume fraction, and collagen fraction
in healthy and tumor tissues for 9 insertions.
*Statistical significant difference.
n indicates the amount of acquired spectra.
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of the presence of a significant amount of fat.
Blood and lipid volume fractions and tissue oxygenation were
significantly greater in normal livers as opposed to tumors (Table 1),
whereas the scattering amplitude was greater in the tumors than in nor-
mal liver tissue (P < 0.05). Within each insertion, the transition from
healthy to tumor tissue is identified as a significant decrease in blood
and lipid content and oxygenation level and as an increase in scattering
amplitude (Figs. 4, 5). The observation that bloodwasmore abundant in
healthy liver tissue correlates with the macroscopic investigations after
tissue resection (Figs. 2C, 3). The kurtosis values indicate that there is a
higher dispersion of the obtained parameter values in tumor than in
healthy tissue (Table 2). For instance, the scattering amplitude in
healthy liver tissue is homogeneous, whereas it is heterogeneous in
the tumor; this correlates with the gross observation that the tumor tis-
sue has a more granular structure (Figs. 2C, 3). In addition, the dif-
ference in tissue homogeneity between the tumor and the healthy part
of the liver is visible on the CBCT images (Fig. 2A). Bile content
was not significantly different between normal and tumor tissues withFIGURE 4. Bar plots with error bars indicating mean and standard
deviation of blood and lipid volume fractions, tissue oxygenation, and
scattering amplitude for a single insertion in healthy and tumor tissue
within a single animal. Figure 4 can be viewed online in color at
www.investigativeradiology.com.
© 2015 Wolters Kluwer Health, Inc. All rights reserved.
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FIGURE 5. Histogram of blood volume fraction, tissue oxygenation,
lipid volume fraction, and scattering amplitude derived from DOS
measurements performed as the needle was inserted from normal to
tumor tissue within a single animal. These data are the source from
which the bar plots in Figure 2 were obtained. Figure 5 can be viewed
online in color at www.investigativeradiology.com.
TABLE 2. Kurtosis of Each Derived Parameter and for Each Insertion
Normal Tumor
Insertion 1
Blood volume fraction 2.9 2.0
Tissue oxygenation 1.4 11.4
Lipid volume fraction 1.3 2.9
Scattering amplitude 1.7 2.0
Bile volume fraction 1.5 2.2
Collagen volume fraction 2.7 4.6
Insertion 2
Blood volume fraction 1.4 4.2
Tissue oxygenation 1.4 5.8
Lipid volume fraction 1.8 4.0
Scattering amplitude 1.8 2.1
Bile volume fraction 10.0 2.3
Collagen volume fraction 2.2 4.2
Insertion 3
Blood volume fraction 2.3 3.0
Tissue oxygenation 3.8 2.5
Lipid volume fraction 2.8 1.7
Scattering amplitude 3.4 1.9
Bile volume fraction 1.6 3.5
Collagen volume fraction 2.0 3.0
Insertion 4
Blood volume fraction 2.2 11.9
Tissue oxygenation 3.0 7.5
Lipid volume fraction 1.5 5.7
Scattering amplitude 4.0 8.1
Bile volume fraction 1.8 28.5
Collagen volume fraction 1.4 3.8
Insertion 5
Blood volume fraction 10.2 4.0
Tissue oxygenation 2.0 1.8
Lipid volume fraction 4.3 4.8
Scattering amplitude 2.1 2.4
Bile volume fraction 3.7 7.4
Collagen volume fraction 1.5 6.7
Insertion 6
Blood volume fraction 2.0 3.5
Tissue oxygenation 6.8 5.2
Lipid volume fraction 1.9 2.0
Scattering amplitude 1.5 4.5
Bile volume fraction 2.0 3.3
Collagen volume fraction 1.6 11.8
Insertion 7
Blood volume fraction 1.9 2.7
Tissue oxygenation 2.3 1.7
Lipid volume fraction 2.5 2.1
Scattering amplitude 2.4 11.0
Bile volume fraction 2.0 1.7
Collagen volume fraction 2.8 6.1
Insertion 8
Blood volume fraction 2.6 6.8
Tissue oxygenation 2.1 3.6
Lipid volume fraction 2.4 5.2
Continued next page
Investigative Radiology • Volume 50, Number 7, July 2015 In Vivo Characterization of Primary Liver Tumorsvalues of 2% ± 2% and 3% ± 3%, respectively (P = 0.65). Most of these
findings were consistent for all 9 insertions except for 1 case in which
the blood content, blood oxygenation, and fat content were comparable
in the tumor tissue and normal tissue.
DISCUSSION
To our knowledge, there have been no previous in vivo liver tu-
mor DOS studies, although there have been a few ex vivo studies that
demonstrate higher scattering amplitude as well as higher lipid, blood,
and bile content in the healthy liver compared with those in the tumor.
However, care should be taken in interpreting ex vivo human studies be-
cause the tissue properties can change very quickly after excision of the
tissue.5 Moreover, the ex vivo studies were done in liver with colorectal
metastases, whereas the present study addresses primary liver tumors;
the comparison of the derived parameters is thus not straightforward.
Therefore, this present in vivo animal study can be considered as a
starting point for future investigations in discriminating HCC from
healthy liver tissue with the DOS technique.
All the woodchucks had signs of chronic infections. This means
that this study shows that the DOS technique can distinguish between
nontumorous liver tissue (with moderate multifocal degeneration and
fibrosis [cirrhosis]) and tumor tissue.11,12
In our study, there was no significant difference in the bile con-
tent, which is most likely due to the fact that the animals have primary
tumors and not metastases from other organs; metastases are made of
abnormal cells from the organ of origin; therefore, no bile is expected
in metastases.13
The existing in vivo studies in the literature were mainly per-
formed in the breast8,9 and the lung2; therefore, only comparisons of
physiological parameters (eg, oxygenation levels and scattering ampli-
tude) in our study to these previous studies are valid, and tissue compo-
sition comparisons are not valid. Our results agree with the general
reported findings from the in vivo human DOS studies.8–10 These stud-
ies demonstrated lower oxygenation levels in the tumor and higher
scattering amplitude, as did our study. However, our study evaluated
the spectral and clinical variations along a needle path as opposed to a
single-point measurement8–10 yielding additional information with re-
spect to the variation in tissue composition across the tumor as well as
identifying the boundary between healthy and tumor tissue. To discrim-
inate a tumor tissue from a nontumor tissue, a discrimination method© 2015 Wolters Kluwer Health, Inc. All rights reserved. www.investigativeradiology.com 447
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TABLE 2. (Continued)
Normal Tumor
Scattering amplitude 3.5 1.4
Bile volume fraction 3.6 2.3
Collagen volume fraction 27.2 5.4
Insertion 9
Blood volume fraction 3.5 4.1
Tissue oxygenation 2.2 2.9
Lipid volume fraction 4.3 3.5
Scattering amplitude 11.0 10.4
Bile volume fraction 2.7 7.3
Collagen volume fraction 2.8 5.6
Kurtosis of the estimated blood volume fraction, blood oxygenation, lipid vol-
ume fraction, scattering amplitude, bile volume fraction, and collagen fraction in
healthy and tumor tissues for 9 insertions.
Nachabé et al Investigative Radiology • Volume 50, Number 7, July 2015based on multiple parameters is required to cope with tumor variability
and heterogeneity. Our study suggests that blood content and oxygena-
tion, lipid content, and scattering are the most promising parameters
that should be further investigated on a larger data set. The information
provided by DOS, such as mapping of blood oxygenation levels along
the needle path, can be of great relevance in the case of biopsy proce-
dures. Hypoxic tissue is often associated with necrosis; therefore, mea-
suring the oxygenation level in tumors can allow the operator to avoid
performing a biopsy in a necrotic region that would not allow conclu-
sive tumor staging by pathologists. Hence, relying on the oxygenation
level in blood is of great interest in performing biopsies.9
In the HCC tumors, the estimated lipid volume fraction and the
pathology slides showed a nonuniform distribution, which is expected
because HCC is known to be associated with patchy macroscopic fatty
change.14 The scattering amplitude related to tissue density is also het-
erogeneous in the tumor, whereas it is more homogenous in the healthy
liver. This observation is in agreement with existing findings on stiff-
ness measurements with US or MR elastography, with tumors being
stiffer than normal liver tissue.15
Changes in the blood content, tissue oxygenation, and scattering
were most notable near the tumor boundary, as can also be observed in
Figure 5. This observation would enable taking biopsies near the tumor
boundary where the likelihood of harvesting vital tissue is greater be-
cause necrosis typically starts in the center of the tumor.
In the last couple of years, a focus on image-based analysis were
developed and validated for HCC diagnosis and staging using CT per-
fusion and optical-based tomography such as bioluminescence.16–18
These new developments enable more accurate identification of the ac-
curate location to be treated that can be used for road map navigation
for interventional radiologists or surgeons for treatment or resection.
The drawback of 3D fluoroscopy is that the information is more qual-
itative than quantitative although it benefits of real-time imaging for
device navigation. More recently, similarly to the presented needle
with DOS sensing as it tips, Kang et al19 developed an electrode with
electromagnetic tracking in US radiofrequency ablation for an im-
proved positioning of the probe to radiate, in an effective way, most
of the tumor to avoid recurrence.19
In conclusion, this study shows the potential of real-time tissue
characterization by DOS measurements at the tip of a needle image-
guided intervention. This first in vivo liver study using diagnostic im-
aging as a reference demonstrates that blood content and tissue oxy-
genation can be used as the primary discriminators for transition
from normal tissue to tumor. Lipid content and scattering amplitude448 www.investigativeradiology.com
Copyright © 2015 Wolters Kluwer Hprovide information on the heterogeneity of tissues along the needle
path. Ultimately, this technology allowing real-time tissue composition
feedback during percutaneous intervention would provide diagnostic
information on the nature of the tumor to immediately treat it (eg, ab-
lation, embolization) without needing to perform a biopsy for patho-
logic evaluation of the tumor and have the patient to come back for a
therapeutic intervention.ACKNOWLEDGMENTS
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